282 related articles for article (PubMed ID: 28095731)
1. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
[TBL] [Abstract][Full Text] [Related]
2. N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.
Impellizzeri D; Siracusa R; Cordaro M; Crupi R; Peritore AF; Gugliandolo E; D'Amico R; Petrosino S; Evangelista M; Di Paola R; Cuzzocrea S
Neurobiol Dis; 2019 May; 125():77-91. PubMed ID: 30660740
[TBL] [Abstract][Full Text] [Related]
3. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.
Esposito E; Paterniti I; Mazzon E; Genovese T; Di Paola R; Galuppo M; Cuzzocrea S
Brain Behav Immun; 2011 Aug; 25(6):1099-112. PubMed ID: 21354467
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
Cordaro M; Scuto M; Siracusa R; D'amico R; Filippo Peritore A; Gugliandolo E; Fusco R; Crupi R; Impellizzeri D; Pozzebon M; Alfonsi D; Mattei N; Marcolongo G; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2020 Mar; 34(3):4085-4106. PubMed ID: 31950563
[TBL] [Abstract][Full Text] [Related]
5. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
[TBL] [Abstract][Full Text] [Related]
7.
Fusco R; Scuto M; Cordaro M; D'Amico R; Gugliandolo E; Siracusa R; Peritore AF; Crupi R; Impellizzeri D; Cuzzocrea S; Di Paola R
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569558
[TBL] [Abstract][Full Text] [Related]
8. The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats.
Siracusa R; Fusco R; Cordaro M; Peritore AF; D'Amico R; Gugliandolo E; Crupi R; Genovese T; Evangelista M; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080989
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
[TBL] [Abstract][Full Text] [Related]
10. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
Paterniti I; Impellizzeri D; Di Paola R; Navarra M; Cuzzocrea S; Esposito E
J Neuroinflammation; 2013 Jul; 10():91. PubMed ID: 23880066
[TBL] [Abstract][Full Text] [Related]
11. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Meli R; Bramanti P; Piomelli D; Calignano A; Cuzzocrea S
J Pharmacol Exp Ther; 2008 Jul; 326(1):12-23. PubMed ID: 18367664
[TBL] [Abstract][Full Text] [Related]
12. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
[TBL] [Abstract][Full Text] [Related]
13. 2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation.
Petrosino S; Campolo M; Impellizzeri D; Paterniti I; Allarà M; Gugliandolo E; D'Amico R; Siracusa R; Cordaro M; Esposito E; Di Marzo V; Cuzzocrea S
Front Pharmacol; 2017; 8():308. PubMed ID: 28611664
[No Abstract] [Full Text] [Related]
14. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Esposito E; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Gugliandolo E; Crupi R; Cuzzocrea S
Eur J Pharmacol; 2016 Jul; 782():107-18. PubMed ID: 27095683
[TBL] [Abstract][Full Text] [Related]
15. Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats.
Ahmad A; Genovese T; Impellizzeri D; Crupi R; Velardi E; Marino A; Esposito E; Cuzzocrea S
Brain Res; 2012 Oct; 1477():45-58. PubMed ID: 23046519
[TBL] [Abstract][Full Text] [Related]
16. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
17. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury.
Cordaro M; Impellizzeri D; Paterniti I; Bruschetta G; Siracusa R; De Stefano D; Cuzzocrea S; Esposito E
J Neurotrauma; 2016 Jan; 33(1):132-46. PubMed ID: 25046306
[TBL] [Abstract][Full Text] [Related]
20. Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice.
Ahmad A; Crupi R; Impellizzeri D; Campolo M; Marino A; Esposito E; Cuzzocrea S
Brain Behav Immun; 2012 Nov; 26(8):1310-21. PubMed ID: 22884901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
